Author： Schreyögg Jonas
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.24, Iss.10, 2006-01, pp. : 999-1009
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US costs highest for AMI hospitalisation
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
Access to resources
Recommend
Opioid-related ADRs: length of stay and hospitalisation costs
Reactions Weekly, Vol. 1, Iss. 1107, 2006-01 ,pp. :
Hospitalisation costs: adult vs paediatric patients
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 353, 2002-01 ,pp. :
Drugs major player in varying hospitalisation costs of CF
Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. :
Drug Disposition in Cystic Fibrosis
By Rey E. Tréluyer J-M. Pons G.
Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. :